Robert R. Ruffolo - 21 Nov 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director
Signature
/s/ Robert Ruffolo
Issuer symbol
ELTX
Transactions as of
21 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 07:34:21 UTC
Previous filing
29 Dec 2023
Next filing
20 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (Right to Buy) Award $0 +4,100 $0.000000 4,100 21 Nov 2024 Common Stock 4,100 $5.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.